Targeting PD-1/PD-L1 in lung cancer: current perspectives

Increased understanding of tumor immunology has led to the development of effective immunotherapy treatments. One of the most important advances in this field has been due to pharmacological design of antibodies against immune checkpoint inhibitors. Anti-PD-1/PD-L1 antibodies are currently in advanc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lung Cancer (Auckl)
Egile Nagusiak: González-Cao, María, Karachaliou, Niki, Viteri, Santiago, Morales-Espinosa, Daniela, Teixidó, Cristina, Sánchez Ruiz, Jesús, Molina-Vila, Miquel Ángel, Santarpia, Mariacarmela, Rosell, Rafael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2015
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217517/
https://ncbi.nlm.nih.gov/pubmed/28210151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S55176
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak